## Background: The limitations of morphologic criteria alone in determining the prognosis for a patient with a particular intermediate-thickness primary melanoma have prompted efforts to identify other markers. ## Methods: In this study, the authors analyzed expression of p53, beta1 integrin, and
Prognostic molecular biomarkers for cutaneous malignant melanoma
β Scribed by Ryo Tanaka; Kazuo Koyanagi; Norihiko Narita; Christine Kuo; Dave S.B. Hoon
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 208 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Thin melanomas can metastasize and be lethal. The predictive importance of tumor thickness in thin melanomas and the specific features identifying the patients at risk have not been investigated fully. Methods. Prognostic factors were analyzed in 585 patients with clinical Stage I invas
We considered, by means of a multivariate approach, trends in survival from cutaneous malignant melanoma in relation to patient and tumor characteristics, using data from the Cancer Registry of the Swiss Canton of Vaud. Between 1980 and 1994, 1,229 cases of incident cutaneous malignant melanoma were
Background and Objectives: Depth of invasion and stage of the disease are established prognostic indicators in cutaneous malignant melanoma. The role of other parameters is still an open problem. Methods: In 93 consecutive patients with cutaneous malignant melanoma, the level of invasion, tumor thic